Search - tctmd.com

Displaying 1 - 20 of 135

Sort: Relevancy | Date

Presentation TCT 2025

TCT 713: Outcomes of Left Atrial Appendage Occlusion vs. Direct Oral Anticoagulants in Atrial Fibrillation: A Systematic Review and Meta-Analysis

Presenter: Zeyad Kholeif

October 27, 2025

Presentation TCT 2025

TCT 710: Plug It or Drug It? Left Atrial Appendage Occlusion vs Direct Acting oral Anticoagulants: A Propensity Matched Real World Analysis of 5-year Outcomes for patients with Atrial Fibrillation

Presenter: Pushan Aggarwal

October 27, 2025

Presentation TCT 2025

TCT 1657: Compressive Coronary Hematoma in Elderly Woman After Initiation of Oral Anticoagulant

Presenter: Kais Ouerghi

October 27, 2025

Presentation TCT 2025

ACS Pharma Trials On The Horizon: Anticoagulants

Presenter: Schuyler Jones

October 26, 2025

Presentation ACC 2025

Extended Anticoagulant Treatment With A Reduced Versus Full Dose Apixaban In Patients With Cancer-associated Venous Thromboembolism: The API-CAT Study

Presenter: Isabelle Mahé

March 29, 2025

Presentation AHA 2024

Efficacy and safety of EdoxabaN in anticoagulant therapy after surgical Bioprosthetic vALVe replacement

Presenter: Chisato Izumi

November 17, 2024

Presentation TCT 2024

Insights from VOYAGER PAD on Anticoagulants in PVI Patients

Presenter: R. Kevin Rogers

October 29, 2024

Presentation NY Valves 2024

Direct Oral Anticoagulants Versus Vitamin K Antagonists After TAVR

Presenter: Agam Bansal

June 06, 2024

Presentation TCT 2023

Keynote Lecture: Which Anticoagulant or Antiplatelet Regimen Post LAAO - The Present and Future?

Presenter: Sanjit Jolly

October 25, 2023

Presentation TCT 2023

TCT 99: Efficacy and safety of early single direct oral anticoagulant therapy within one year after coronary stent implantation in patients with atrial fibrillation

Presenter: Taehoon Kim

October 25, 2023

Presentation TCT 2023

TCT 657: Aspirin versus P2Y12 inhibitor as a combination therapy with direct oral anticoagulant after coronary stent implantation in patients with atrial fibrillation (AF).

Presenter: Hyunki LEE

October 25, 2023

Presentation TCT 2023

STEMI Pharmacotherapy: Oral and IV Antiplatelet Therapies, Intracoronary Lytic, Anticoagulants, and Early PCSK9 Inhibitors

Presenter: Sanjit Jolly

October 25, 2023

Presentation TCT 2023

A Randomized Clinical Trial of a Novel Triple Drug Eluting Coronary Implant Eluting Two Anticoagulants and Sirolimus: Six-Month Clinical and Imaging Results of the DESyne BDS Plus Study

Presenter: Stefan Verheye

October 25, 2023

Presentation TVT 2023

Direct Oral Anticoagulants Versus Vitamin K Antagonists in Atrial Fibrillation Patients With Bioprosthetic Valves: A Systematic Review, Meta-Analysis and Network Meta-Analysis

Presenter: Mustafa Suppah

June 08, 2023

Presentation TVT 2023

Comparative Effectiveness of Left Atrial Appendage Closure and Direct Oral Anticoagulants in Atrial Fibrillation Patients: A Meta-Analysis

Presenter: Olayiwola Bolaji

June 08, 2023

Presentation TCT 2022

TCT 362: Direct-acting Oral Anticoagulants versus Vitamin K Antagonists in Patients Undergoing Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-analysis

Presenter: Khawaja Akhtar

September 19, 2022

Presentation TCT 2022

TCT 359: Continued Oral Anticoagulation With Non-Vitamin K Antagonist Oral Anticoagulants Versus Vitamin K Antagonists in Transcatheter Aortic Valve Implantation

Presenter: Norman Mangner

September 19, 2022

Presentation TCT 2022

TCT 381: Vitamin K Antagonists, Direct Oral Anticoagulants, or Left Atrial Appendage Closure for Patients with Nonvalvular Atrial Fibrillation: A Systematic Review and Network Meta-Analysis

Presenter: Davide Cao

September 18, 2022

Presentation TVT 2022

Real World Outcomes of Left Atrial Appendage Occlusion compared to Novel Oral Anticoagulants - A multicenter electronic health record analysis

Presenter: Arka Chatterjee

June 10, 2022

Presentation TCT 2020

TCT 449: Direct Oral Anticoagulants vs. Warfarin Following Left Atrial Appendage Occlusion: A Study-Level Meta-Analysis

Presenter: Aravdeep Jhand

October 14, 2020

Advertisement

TCT 713: Outcomes of Left Atrial Appendage Occlusion vs. Direct Oral Anticoagulants in Atrial Fibrillation: A Systematic Review and Meta-Analysis

TCT 710: Plug It or Drug It? Left Atrial Appendage Occlusion vs Direct Acting oral Anticoagulants: A Propensity Matched Real World Analysis of 5-year Outcomes for patients with Atrial Fibrillation

TCT 1657: Compressive Coronary Hematoma in Elderly Woman After Initiation of Oral Anticoagulant

ACS Pharma Trials On The Horizon: Anticoagulants

Extended Anticoagulant Treatment With A Reduced Versus Full Dose Apixaban In Patients With Cancer-associated Venous Thromboembolism: The API-CAT Study

Efficacy and safety of EdoxabaN in anticoagulant therapy after surgical Bioprosthetic vALVe replacement

Insights from VOYAGER PAD on Anticoagulants in PVI Patients

Direct Oral Anticoagulants Versus Vitamin K Antagonists After TAVR

Keynote Lecture: Which Anticoagulant or Antiplatelet Regimen Post LAAO - The Present and Future?

TCT 99: Efficacy and safety of early single direct oral anticoagulant therapy within one year after coronary stent implantation in patients with atrial fibrillation

TCT 657: Aspirin versus P2Y12 inhibitor as a combination therapy with direct oral anticoagulant after coronary stent implantation in patients with atrial fibrillation (AF).

STEMI Pharmacotherapy: Oral and IV Antiplatelet Therapies, Intracoronary Lytic, Anticoagulants, and Early PCSK9 Inhibitors

A Randomized Clinical Trial of a Novel Triple Drug Eluting Coronary Implant Eluting Two Anticoagulants and Sirolimus: Six-Month Clinical and Imaging Results of the DESyne BDS Plus Study

Direct Oral Anticoagulants Versus Vitamin K Antagonists in Atrial Fibrillation Patients With Bioprosthetic Valves: A Systematic Review, Meta-Analysis and Network Meta-Analysis

Comparative Effectiveness of Left Atrial Appendage Closure and Direct Oral Anticoagulants in Atrial Fibrillation Patients: A Meta-Analysis

TCT 362: Direct-acting Oral Anticoagulants versus Vitamin K Antagonists in Patients Undergoing Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-analysis

TCT 359: Continued Oral Anticoagulation With Non-Vitamin K Antagonist Oral Anticoagulants Versus Vitamin K Antagonists in Transcatheter Aortic Valve Implantation

TCT 381: Vitamin K Antagonists, Direct Oral Anticoagulants, or Left Atrial Appendage Closure for Patients with Nonvalvular Atrial Fibrillation: A Systematic Review and Network Meta-Analysis

Real World Outcomes of Left Atrial Appendage Occlusion compared to Novel Oral Anticoagulants - A multicenter electronic health record analysis

TCT 449: Direct Oral Anticoagulants vs. Warfarin Following Left Atrial Appendage Occlusion: A Study-Level Meta-Analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content